A PHASE I RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A LIVE-ATTENUATED TETRAVALENT DENGUE VACCINE (V181) IN FLAVIVIRUS-NAIVE AND FLAVIVIRUS- EXPERIENCED HEALTHY ADULTS

被引：0
|
作者：
Russell, Kevin [1 ]
Rupp, Richard [2 ]
Morales-Ramirez, Javier [3 ]
Diaz-Perez, Clemente [4 ]
Andrews, Charles [5 ]
Davis, Matthew [6 ]
Lee, Andrew [1 ]
Finn, Tyler [1 ]
Russell, Amy Falk [1 ]
Schaller, Margaret [1 ]
Martin, Jason [1 ]
Hyatt, Donna [1 ]
Gozlan-Kelner, Sabrina [1 ]
Stek, Jon [1 ]
Coller, Beth-Ann [1 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Univ TX Med Branch, Galveston, TX USA
[3] Ashford Presbyterian Community Hosp, San Juan, PR USA
[4] Univ Puerto Rico, San Juan, PR 00936 USA
[5] Diagnost Res Grp, San Antonio, TX USA
[6] Rochester Clin Res, Rochester, NY USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2019年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
199
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [1] A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naive and flavivirus-experienced healthy adults
    Russell, Kevin L.
    Rupp, Richard E.
    Morales-Ramirez, Javier O.
    Diaz-Perez, Clemente
    Andrews, Charles P.
    Lee, Andrew W.
    Finn, Tyler S.
    Cox, Kara S.
    Falk Russell, Amy
    Schaller, Margaret M.
    Martin, Jason C.
    Hyatt, Donna M.
    Gozlan-Kelner, Sabrina
    Bili, Androniki
    Coller, Beth-Ann G.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [2] Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants
    Watanaveeradej, Veerachai
    Simasathien, Sriluck
    Nisalak, Ananda
    Endy, Timothy P.
    Jarman, Richard G.
    Innis, Bruce L.
    Thomas, Stephen J.
    Gibbons, Robert V.
    Hengprasert, Sumetha
    Samakoses, Rudiwilai
    Kerdpanich, Angkool
    Vaughn, David W.
    Putnak, J. Robert
    Eckels, Kenneth H.
    De la Barrera, Rafael
    Mammen, Mammen P., Jr.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2011, 85 (02): : 341 - 351
  • [3] Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
    Osorio, Jorge E.
    Velez, Ivan D.
    Thomson, Cynthia
    Lopez, Liliana
    Jimenez, Alejandra
    Haller, Aurelia A.
    Silengo, Shawn
    Scott, Jaclyn
    Boroughs, Karen L.
    Stovall, Janae L.
    Luy, Betty E.
    Arguello, John
    Beatty, Mark E.
    Santangelo, Joseph
    Gordon, Gilad S.
    Huang, Claire Y-H
    Stinchcomb, Dan T.
    LANCET INFECTIOUS DISEASES, 2014, 14 (09): : 830 - 838
  • [4] A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults
    Gunale, Bhagwat
    Farinola, Nicholas
    Yeolekar, Leena
    Shrivastava, Shubham
    Girgis, Hanna
    Poonawalla, Cyrus S.
    Dhere, Rajeev M.
    Arankalle, Vidya
    Mishra, Akhilesh Chandra
    Mehla, Rajeev
    Kulkarni, Prasad S.
    VACCINE, 2023, 41 (38) : 5614 - 5621
  • [5] Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults
    Sun, Wellington
    Cunningham, Dennis
    Wasserman, Steven S.
    Perry, Judith
    Putnak, J. Robert
    Eckels, Kenneth H.
    Vaughn, David W.
    Thomas, Stephen J.
    Kanesa-Thasan, Niranjan
    Innis, Bruce L.
    Edelman, Robert
    HUMAN VACCINES, 2009, 5 (01): : 33 - 40
  • [6] Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial
    George, Sarah L.
    Wong, Mimi A.
    Dube, Tina J. T.
    Boroughs, Karen L.
    Stovall, Janae L.
    Luy, Betty E.
    Haller, Aurelia A.
    Osorio, Jorge E.
    Eggemeyer, Linda M.
    Irby-Moore, Sharon
    Frey, Sharon E.
    Huang, Claire Y. -H.
    Stinchcomb, Dan T.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (07): : 1032 - 1041
  • [7] Safety and immunogenicity of a single dose, live-attenuated 'tetravalent dengue vaccine' in healthy Indian adults; a randomized, double-blind, placebo controlled phase I/II trial
    Mohanty, Lalitendu
    Prabhu, Madhav
    Mishra, Amit Kumar
    Purty, Anil J.
    Kanungo, Reba
    Ghosh, Goutam
    Kumar, R. Prahan
    Raj, A. Newton
    Bhushan, Sumit
    Jangir, Manoj Kumar
    Gupta, Anu
    Bhakri, Anju
    VACCINE: X, 2022, 10
  • [8] Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naive adults
    Manoff, Susan B.
    Sausser, Michele
    Russell, Amy Falk
    Martin, Jason
    Radley, David
    Hyatt, Donna
    Roberts, Christine C.
    Lickliter, Jason
    Krishnarajah, Janakan
    Bett, Andrew
    Dubey, Sheri
    Finn, Tyler
    Coller, Beth-Ann
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (09) : 2195 - 2204
  • [9] A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
    Durbin, Anna P.
    Kirkpatrick, Beth D.
    Pierce, Kristen K.
    Elwood, Daniel
    Larsson, Catherine J.
    Lindow, Janet C.
    Tibery, Cecilia
    Sabundayo, Beulah P.
    Shaffer, Donna
    Talaat, Kawsar R.
    Hynes, Noreen A.
    Wanionek, Kimberli
    Carmolli, Marya P.
    Luke, Catherine J.
    Murphy, Brian R.
    Subbarao, Kanta
    Whitehead, Stephen S.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (06): : 957 - 965
  • [10] Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
    Kallas, Esper G.
    Precioso, Alexander Roberto
    Palacios, Ricardo
    Thome, Beatriz
    Braga, Patricia Emilia
    Vanni, Tazio
    Campos, Lucia M. A.
    Ferrari, Lilian
    Mondini, Gabriella
    Salomao, Maria da Graca
    da Silva, Anderson
    Espinola, Heloisa M.
    Santos, Joane do Prado
    Santos, Cecilia L. S.
    Timenetsky, Maria do Carmo S. T.
    Miraglia, Joao Luiz
    Gallina, Neuza M. F.
    Weiskopf, Daniela
    Sette, Alessandro
    Goulart, Raphaella
    Salles, Rafael Tavares
    Maestri, Alvino
    Sallum, Adriana Maluf Elias
    Farhat, Sylvia Costa Lima
    Sakita, Neusa K.
    Ferreira, Juliana C. O. A.
    Silveira, Cassia G. T.
    Costa, Priscilla R.
    Raw, Isaias
    Whitehead, Stephen S.
    Durbin, Anna P.
    Kalil, Jorge
    LANCET INFECTIOUS DISEASES, 2020, 20 (07): : 839 - 850
12345